| 摘要 |
<p>The present invention relates to a method for producing patient cancerous disease modifying antibodies using a novel paradigm of screening. By segreg ating the anti-cancer antibodies using cancer cell cytotoxicity as an end po int, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of s taging and diagnosis of a cancer, and can be used to treat primary tumors an d tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells.</p> |
